We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at ...

A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with ...

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate ...

Investing.com-- Eli Lilly and Company (NYSE:LLY) said on Tuesday evening that China’s food and drug regulator had approved its ...

Highlights,Institutional investors have adjusted their holdings in Eli Lilly and Company, with several firms increasing ...

The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The sequence contained a promising new genetic tool for modifying DNA, a CRISPR. Editas Medicine, a Massachusetts-based ...

President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and ...

How is the ownership structure of Hershey set up ... is looking a lot like a growth stock. Eli Lilly reported this morning. I want to talk about their revenue growth number, and I'm going to ...

Where some saw an imperfect compromise, other attendees apparently left the talks in disgust. In published reports, for ...